Grantham, Mayo, Van Otterloo & Co (GMO)’s CareTrust REIT CTRE Stock Holding History
Bought
Maintained
Sold
Other funds holding CTRE
BPSG
CIM
Grantham, Mayo, Van Otterloo & Co (GMO)'s CTRE Position: Q4 2019 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CareTrust REIT (CTRE) in Q4 2019, closing a stake of 24,800 shares — an estimated $583K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CTRE in Q2 2019 and held it in 2 quarters. The position peaked at $2.19M in Q2 2019. 218 funds tracked by Wall St. Rank hold CTRE as of Q4 2019.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CareTrust REIT position as of Q4 2019 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 24,800 CareTrust REIT shares in Q4 2019, an estimated $583K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CareTrust REIT in Q2 2019 and held it in 2 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s CareTrust REIT position peaked at $2.19M in Q2 2019.
- 218 funds tracked by Wall St. Rank held CareTrust REIT as of Q4 2019.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2019, filed 13 Feb 2020.